Fracaso de la terapia endoscópica para la metaplasia de Barrett displásica o para el cáncer esofágico temprano

1. C. Bennett, N. Vakil, J. Bergman et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process Gastroenterology, 143 (2012), pp. 336–3460
2. B.F. Overholt, C.J. Lightdale, K.K. Wang et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial Gastrointest Endosc, 62 (2005), pp. 488–498
3. N.J. Shaheen, P. Sharma, B.F. Overholt et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med, 360 (2009), pp. 2277–2288
4. C. Ell, A. May, L. Gossner et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology, 118 (2000), pp. 670–677
5. H.C. Wolfsen, L.L. Hemminger, M.B. Wallace, K.R. Devault Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther, 20 (2004), pp. 1125–1131
6. F.P. Peters, M.A. Kara, W.D. Rosmolen et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc, 61 (2005), pp. 506–514
7. C. Ell, A. May, O. Pech et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc, 65 (2007), pp. 3–10
8. R.A. Ganz, B.F. Overholt, V.K. Sharma et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc, 68 (2008), pp. 35–40
9. O. Pech, A. Behrens, A. May et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut, 57 (2008), pp. 1200–1206
10. G.A. Prasad, T.T. Wu, D.A. Wigle et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology, 137 (2009), pp. 815–823
11. R.J. Badreddine, G.A. Prasad, K.K. Wang et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc, 71 (2010), pp. 697–703
12. W.D. Lyday, F.S. Corbett, D.A. Kuperman et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy, 42 (2010), pp. 272–278
13. R.E. Pouw, K. Wirths, P. Eisendrath et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol, 8 (2010), pp. 23–29
14. R.J. Korst, S. Santana-Joseph, J.R. Rutledge et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg, 142 (2011), pp. 1168–1173
15. O. Pech, E. Bollschweiler, H. Manner, J. Leers, C. Ell, A.H. Hölscher. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg, 254 (2011), pp. 67–72
16. N.J. Shaheen, B.F. Overholt, R.E. Sampliner et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology, 141 (2011), pp. 460–468
17. J. Zehetner, S.R. DeMeester, J.A. Hagen et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma- J Thorac Cardiovasc Surg, 141 (2011), pp. 39–47
18. F. Caillol, E. Bories, C. Pesenti et al. Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol, 36 (2012), pp. 371–377
19. R.A. Luna, E. Gilbert, J.G. Hunter. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol, 28 (2012), pp. 362–369
20. B.J. Reid, D.S. Levine, G. Longton, P.L. Blount, P.S. Rabinovitch. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol, 95 (2000), pp. 1669–1676
21. P. Mccann, T. Stafinski, C. Wong, D. Menon. The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: a systematic review. Cancer Treat Rev, 37 (2011), pp. 11–62
22. C. Tharavej, J.A. Hagen, J.H. Peters et al. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc, 20 (2006), pp. 439–443
23. M. Titi, A. Overhiser, O. Ulusarac et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology, 143 (2012), pp. 564–566.e1
24. J.L. Hornick, P.L. Blount, C.A. Sanchez et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol, 29 (2005), pp. 372–380
25. C.G. Peyre, S.R. DeMeester, C. Rizzetto et al. Vagal-sparing esophagectomy. Ann Surg, 246 (2007), pp. 665–671 discussion 671–4
26. G. Zaninotto, A.R. Parenti, A. Ruol, M. Costantini, S. Merigliano, E. Ancona. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg, 87 (2000), pp. 1102–1105
27. E.E. Tseng, T.T. Wu, C.J. Yeo, R.F. Heitmiller. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome—an update. J Gastrointest Surg, 7 (2003), pp. 164–170 discussion 170–1
28. V. Sujendran, G. Sica, B. Warren, N. Maynard. Oesophagectomy RMEains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg, 28 (2005), pp. 763–766
29. R. Mirnezami, A. Rohatgi, R.P. Sutcliffe, A. Hamouda, R.C. Mason. Transhiatal oesophagectomy: treatment of choice for high-grade dysplasia. Eur J Cardiothorac Surg, 36 (2009), pp. 364–367
30. A.J. Cameron, H.A. Carpenter. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gasteroenterol, 92 (1997), pp. 586–591